IRIS UniCatt

Grieco, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.309
NA - Nord America 6.586
AS - Asia 3.023
SA - Sud America 540
AF - Africa 45
OC - Oceania 31
Continente sconosciuto - Info sul continente non disponibili 26
Totale 17.560
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.518
DE - Germania 2.948
SE - Svezia 1.341
CN - Cina 1.182
SG - Singapore 1.050
IT - Italia 706
UA - Ucraina 694
BR - Brasile 490
IE - Irlanda 372
FR - Francia 290
GB - Regno Unito 264
ID - Indonesia 232
FI - Finlandia 212
RU - Federazione Russa 190
TR - Turchia 169
IN - India 163
PL - Polonia 70
HK - Hong Kong 43
BE - Belgio 42
CA - Canada 39
NL - Olanda 36
AT - Austria 32
KR - Corea 30
JP - Giappone 27
IR - Iran 26
AU - Australia 25
EU - Europa 22
VN - Vietnam 20
AR - Argentina 15
RO - Romania 15
CH - Svizzera 13
CZ - Repubblica Ceca 11
PE - Perù 11
PT - Portogallo 11
CI - Costa d'Avorio 10
ES - Italia 10
IL - Israele 10
MX - Messico 10
BD - Bangladesh 8
HU - Ungheria 8
PK - Pakistan 8
EG - Egitto 7
IQ - Iraq 7
LT - Lituania 7
MA - Marocco 7
PA - Panama 7
AE - Emirati Arabi Uniti 6
DK - Danimarca 6
EC - Ecuador 6
NZ - Nuova Zelanda 6
ZA - Sudafrica 6
BZ - Belize 5
CL - Cile 5
CO - Colombia 5
GR - Grecia 5
MK - Macedonia 5
BO - Bolivia 4
EE - Estonia 4
KG - Kirghizistan 4
LK - Sri Lanka 4
PH - Filippine 4
TH - Thailandia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AZ - Azerbaigian 3
GE - Georgia 3
KH - Cambogia 3
MY - Malesia 3
NG - Nigeria 3
NO - Norvegia 3
SC - Seychelles 3
VE - Venezuela 3
AL - Albania 2
BG - Bulgaria 2
IS - Islanda 2
JM - Giamaica 2
KE - Kenya 2
MD - Moldavia 2
PR - Porto Rico 2
SD - Sudan 2
TN - Tunisia 2
UZ - Uzbekistan 2
A1 - Anonimo 1
BH - Bahrain 1
BY - Bielorussia 1
CG - Congo 1
CR - Costa Rica 1
CY - Cipro 1
DJ - Gibuti 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
JO - Giordania 1
KW - Kuwait 1
KZ - Kazakistan 1
LU - Lussemburgo 1
LV - Lettonia 1
MC - Monaco 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
Totale 17.553
Salva come PNG Salva come JPEG
Città #
Chandler 1.347
Singapore 611
Ashburn 479
Jacksonville 405
Dublin 370
San Mateo 334
Nanjing 237
Jakarta 227
Ann Arbor 223
Wilmington 195
Nürnberg 180
Boston 178
New York 160
Cattolica 151
Izmir 151
Houston 149
Dearborn 139
Princeton 123
Milan 119
Woodbridge 119
Munich 115
Moscow 112
Beijing 110
Rome 100
Marseille 99
Nanchang 98
Boardman 75
Seattle 74
Los Angeles 69
Redwood City 68
Lawrence 66
Helsinki 65
The Dalles 64
Chicago 63
Redmond 63
Fairfield 57
Hebei 55
Kraków 55
Tianjin 53
Frankfurt am Main 52
Mountain View 46
Bremen 45
Shenyang 44
Brussels 42
Kunming 42
Hefei 39
Hong Kong 39
University Park 39
Jiaxing 37
Zhengzhou 37
Norwalk 36
São Paulo 36
Changsha 35
Guangzhou 33
Hangzhou 32
San Jose 31
Augusta 28
Fremont 28
Seoul 28
Jinan 27
Düsseldorf 26
Washington 25
London 24
Cambridge 22
Andover 21
Nuremberg 21
Falls Church 20
Pune 20
Simi Valley 20
Santa Clara 19
Hyderabad 17
Lancaster 17
Ningbo 17
Saint Petersburg 17
San Francisco 17
Rio de Janeiro 16
Leawood 15
Shanghai 15
Vienna 15
Belo Horizonte 14
Lanzhou 14
San Diego 13
Taizhou 13
Toronto 13
Amsterdam 12
Detroit 12
Lauterbourg 12
Paris 12
Phoenix 12
Stockholm 12
Falkenstein 11
Warsaw 11
Abidjan 10
Atlanta 10
Brooklyn 10
Indiana 10
Kish 10
Ottawa 10
Brno 9
Changchun 9
Totale 8.737
Salva come PNG Salva come JPEG
Nome #
Gastrointestinal amyloidosis: a case of chronic diarrhoea. 283
Practice guidelines for the treatment of hepatitis C: recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting. 269
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 221
13C-methionine breath tests for mitochondrial liver function assessment. 215
A phase II study of sunitinib in advanced hepatocellular carcinoma 213
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 192
Abdominal angina due to recurrence of cancer of the papilla of vater: a case report. 188
-Hepatic steatosis and vascular disease 180
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 167
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 167
134C-breath tests in the study of mitochondrial liver function 164
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 164
Severe veno-occlusive disease after autologous peripheral blood stem cell transplantation for high-grade non-Hodgkin lymphoma: report of a successfully managed case and a literature review of veno-occlusive disease. 162
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 157
Prospective study of hepatitis B virus reactivation in patients with hematological malignancies 156
Effect of sildenafil on diabetic gastropathy. 151
Radiofrequency ablation plus drug-eluting beads transcatheter arterial chemoembolization for the treatment of single large hepatocellular carcinoma 146
13C-breath tests in the study of microsomial liver function 145
Safety and efficacy profile of G-CSF therapy in patients with acute on chronic liver failure 144
13C-methionine breath tests for mitochondrial liver function assessment 142
Epicardial fat thickness correlates with body fat stores, insulin resistance and alanine aminotransferase in patients affected by nonalcoholic steatohepatitis (NASH) 137
recurrent acute hepatitis associated with use of cetrizine 134
Contrast-enhanced ultrasound assessment of arterial vascularization of small nodules arising in the cirrhotic liver 132
Potential use of liver function breath tests in the clinical practice. 129
The Effect of CYP, GST, and SULT Polymorphisms and Their Interaction with Smoking on the Risk of Hepatocellular Carcinoma 129
Vanishing-recurrent benign liver lesions 128
[Oxidative stress in metabolic syndrome and nonalcoholic steatohepatitis. Is it possible a role for vitamins in clinical practice?] 127
gc) Celiac disease in the 21st century: issues of under- and over-diagnosis 123
Hepatocellular carcinoma treated by conventional transarterial chemoembolization in field-practice: serum sodium predicts survival 123
13C-breath tests in the study of mitochondrial liver function 122
Cryoglobulinemia: a true internistic disease? 121
Clopidogrel-induced neutropenia after coronary stenting: is cilostazol a good alternative? 118
[The treatment of hepatocellular carcinoma: an update] 117
L'insufficienza epatica: algoritmi diagnostici e trattamenti medici 115
Nonalcoholic fatty liver disease is associated with increased GHBP and reduced GH/IGF-I levels 115
-Fatty liver and drugs 114
Hepatitis C in the elderly: A multicentre cross-sectional study by the Italian Association for the Study of the Liver 114
Faecal calprotectin concentrations in untreated coeliac patients 114
Noninvasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). 113
A "systems medicine" approach to the study of non-alcoholic fatty liver disease 113
Tromboembolism and breast cancer: the hidden risk for patient and physician 112
Quando e perché fermarsi nelle terapie: l’opinione del clinico e del bioeticista sui casi di HCC avanzato. 112
gastroesophageal reflux disease: facts and uncertaines 111
A case-control study on the effects of the apolipoprotein E genotypes in nonalcoholic fatty liver disease 110
Evaluation of the albumin-gamma-glutamyl transferase isoenzyme as a diagnostic marker of hepatocellular carcinoma-complicating liver cirrhosis. 109
Liver transplantation in patients with alcoholic liver disease: A retrospective study 108
Cystic lymphangioma of the mesentery and hyposplenism in celiac disease. 107
A case-control study on the effect of metabolic gene polymorphisms, nutrition, and their interaction on the risk of non-alcoholic fatty liver disease 107
Bone metastasis in hepatocellular carcinoma. A report of five cases and a review of the literature. 106
Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets 106
Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre. 105
Liver resection for hepatocellular carcinoma in patient with situs inversus viscerum 105
Intestinal permeability after Mediterranean diet and low-fat diet in non-alcoholic fatty liver disease 105
Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: a randomized controlled trial 103
Liver metastases of endocrine tumour associated with multiple endocrine neoplasia type 1: a sustained response to interferon therapy or a peculiar benign course? 100
High Prevalence and Gender-Related Differences of Gastrointestinal Manifestations in a Cohort of DM1 Patients: A Perspective, Cross-Sectional Study 100
FAECAL CALPROTECTIN CONCENTRATIONS IN UNTREATED CELIAC PATIENTS 99
[Natural history, diagnosis and treatment of chronic hepatitis B and C in hemodialysis patients] 99
Comment on "the role of endoscopic ultrasound in the evaluation of chronic mesenteric ischaemia" 98
Severe giant cell arteritis associated with essential thrombocythaemia. 97
-Nonalcoholic fatty liver disease: defining a common problem 97
Genetic susceptibility of increased intestinal permeability is associated with progressive liver disease and diabetes in patients with non-alcoholic fatty liver disease 96
Hepatic mitochondrial beta-oxidation in patients with nonalcoholic steatohepatitis assessed by 13C-octanoate breath test. 95
Gallstone disease is associated with more severe liver damage in patients with non-alcoholic Fatty liver disease 95
Antipyrine clearance in chronic and neoplastic liver diseases: a study of 518 patients. 95
An update on clinical applications of hepatospecific contrast media in magnetic resonance imaging of liver parenchyma 95
Alcoholic and nonalcoholic forms of fatty liver disease. 94
Advanced colon cancer: staging and prognosis by CEA test 93
Severe acute hepatitis after resumption of interferon-Beta therapy for multiple sclerosis: a word of caution. 91
Sarco-Model: A score to predict the dropout risk in the perspective of organ allocation in patients awaiting liver transplantation 90
Contrast-enhanced ultrasound in the short-term evaluation of hepatocellular carcinoma after locoregional treatment 88
Low-dose lactose in drugs neither increases breath hydrogen excretion nor causes gastrointestinal symptoms. 87
Gut-liver axis and microbiota in NAFLD: insight pathophysiology for novel therapeutic target 86
Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk 86
Impact of new DAA therapy on real clinical practice: A multicenter region-wide cohort study 86
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 86
Braised liver with herbs: the risks of naturopathic hepatoprotection. 85
A "systems medicine" approach to the study of non-alcoholic fatty liver disease 85
Gender affects 13C-ketoisocaproic acid breath test 84
A giant calcified hepatic mass 83
Prevalence and Risk Factors Associated with Use of QT-Prolonging Drugs in Hospitalized Older People 83
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 83
The diagnostic performance of PIVKA-II in metabolic and viral hepatocellular carcinoma: A pilot study 83
Socio-demographic determinants of coinfections by HIV, hepatitis B and hepatitis C viruses in central Italian prisoners. 82
Drug-induced hepatitis 82
Review article: breath testing for human liver function assessment. 82
Multimorbidity and polypharmacy in the elderly: lessons from REPOSI 82
A case-control study on the effect of metabolic gene polymorphisms, nutrition, and their interaction on the risk of non-alcoholic fatty liver disease 82
Mediterranean diet and the prevention of non-alcoholic fatty liver disease: Results from a case-control study 82
Erythrocyte viscoelastic recovery after liver transplantation in a cirrhotic patient affected by spur cell anaemia 82
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma 81
Is coeliac disease a confounding factor in the diagnosis of NASH? 80
A peculiar cause of small-bowel intussusception and iron deficiency anaemia 80
Liver Resection versus Radiofrequency Ablation plus Transcatheter Arterial Chemoembolization in Cirrhotic Patients with Solitary Large Hepatocellular Carcinoma 79
A novel ABCB11 variant in compound heterozygosity: BRIC2 or PFIC2? 78
Acute fatty liver after malaria prophylaxis with mefloquine 78
Enhanced liver fibrosis test as a reliable tool for assessing fibrosis in nonalcoholic fatty liver disease in a clinical setting 78
NON ALCOHOLIC STEATOHEPATITIS (NASH) INDUCED BY CARBAMAZEPINE AND VARIEGATE PORPHYRIA 76
Impairment of recent thymic emigrants in HCV infection. 75
A case of esomeprazole-induced transient diabetes and hepatitis: the role of liver inflammation in the pathogenesis of insulin resistance 75
Totale 11.563
Salva come PNG Salva come JPEG
Categoria #
all - tutte 81.867
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.867
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020368 0 0 0 0 0 0 0 0 0 0 178 190
2020/20211.524 89 166 77 172 190 63 161 32 194 71 277 32
2021/20221.753 69 162 46 177 124 43 29 288 62 87 320 346
2022/20233.675 487 486 288 539 270 441 158 336 425 46 145 54
2023/20241.812 119 540 71 84 73 262 115 64 23 71 158 232
2024/20253.013 99 108 323 120 295 143 84 212 584 391 654 0
Totale 17.782